Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) Return on equity

Alert me on Return on equity

Surgery Partners, Inc.'s return on equity over the twelve months to 30 June 2026 was −2.83%, down 0.4 percentage points from fiscal 2025 (−2.46%). Over the past ten years it has ranged from −19.6% (fiscal 2018) to 3.04% (fiscal 2016); the current reading is higher than 64% of that period. That is below the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.

Return on equity, annual

Embed this chart

Annual newest first

Period Return on equity Change (points)
FY2025 −2.46% 2.94
FY2024 −5.40% (5.00)
FY2023 −0.40% 1.82
FY2022 −2.22% 3.47
FY2021 −5.69% 10.99
FY2020 −16.7% (6.07)
FY2019 −10.6% 8.94
FY2018 −19.6% (10.03)
FY2017 −9.52% (12.56)
FY2016 3.04% 2.17

Against its own ten years

Low −19.6% High 3.04%
Ten-year median −5.40%
Current reading's percentile 64

Return on equity against peers

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on SGRY